Petition to Save Disposable E-cigarettes and Fruit Flavors

Regulations by 2FIRSTS.ai
Dec.11.2023
Petition to Save Disposable E-cigarettes and Fruit Flavors
UKVIA urges smokers, e-cigarette users, and industry professionals to petition against UK government banning disposable and fruit-flavored e-cigarettes.

In recent days, according to an announcement on the official website of the UK Vaping Industry Association (UKVIA), the organization is making an unprecedented call for smokers, e-cigarette users, and stakeholders in the industry nationwide to unite and launch a petition. The aim is to urge the UK government not to ban the sale of disposable e-cigarettes and e-cigarettes with fruit flavors.

 

The commencement of this petition campaign is closely tied to the ongoing public consultation on the issue of youth e-cigarette usage. The open consultation will conclude on December 6th.

 

This petition reveals to the general public the potentially severe public health consequences of "excessive and counterproductive legislation" that could undermine the effectiveness of e-cigarettes as a smoking cessation tool. It warns that blocking access to fruit-flavored e-cigarettes and disposable e-cigarettes could deter adult smokers from transitioning to e-cigarettes, as the majority of smokers who want to quit depend on these flavors and disposable options.

 

In light of this, the UK e-cigarette industry association is currently engaging directly with its members, advocacy groups such as WeVape, and online communities with over 100,000 adult e-cigarette users, urging them to take immediate action to boycott. The association is also actively promoting its cause on social media platforms, aiming to increase the number of petition signatures to the fullest extent possible. Moreover, real-life testimonies are being shared to illustrate how e-cigarettes have helped individuals quit smoking and enhance their quality of life.

 

John Dunne, the General Secretary of the Association, stated that "banning heavyweight e-cigarettes and flavored e-cigarettes could potentially be the most severe setback to public health in this century, and may even set back the progress towards smoke-free environments by several years.

 

He emphasized the importance of not allowing these products to fall into the hands of minors and preventing teenagers from being exposed to e-cigarettes. However, it must not be at the expense of sacrificing the possibility of adult smokers quitting cigarettes.

 

Furthermore, Deng En also expressed that if the ban on disposable products or fruit-flavored e-cigarettes is implemented, it could potentially fuel a rapid increase in black market sales, providing an economic source for criminals and potentially giving rise to unregulated and potentially hazardous illegal products. Similar situations have already been witnessed in countries like Australia.

 

To this end, the association has specifically initiated this petition campaign to provide a platform for millions of adult individuals who have successfully quit smoking through disposable e-cigarettes and fruit-flavored e-cigarettes to have a voice.

 

The new petition initiative is part of the "Save Vaping, Save Lives" campaign, which also includes providing information to association members, encouraging and mobilizing e-cigarette users to participate in government consultations on youth e-cigarette use. Further details about the "Save Vaping, Save Lives" campaign and the petition can be found on the official website of the UK E-Cigarette industry association.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03